Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024)

Simply Wall St.11-14

Intelligent Bio Solutions (NASDAQ:INBS) First Quarter 2025 ResultsKey Financial Results Revenue: US$872.3k (up 9.6% from 1Q 2024). Net loss: US$2.69m (loss widened by 11% from 1Q 2024). US$0.70 loss ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483286696?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2024-11-14 02:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483286696","market":"us","top_or_hot":-1,"title":"Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024)","media":"Simply Wall St.","content":"<div>\n<p>Intelligent Bio Solutions (NASDAQ:INBS) First Quarter 2025 ResultsKey Financial Results Revenue: US$872.3k (up 9.6% from 1Q 2024). Net loss: US$2.69m (loss widened by 11% from 1Q 2024). US$0.70 loss ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-inbs/intelligent-bio-solutions/news/intelligent-bio-solutions-first-quarter-2025-earnings-us070\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-14 02:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-inbs/intelligent-bio-solutions/news/intelligent-bio-solutions-first-quarter-2025-earnings-us070><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Intelligent Bio Solutions (NASDAQ:INBS) First Quarter 2025 ResultsKey Financial Results Revenue: US$872.3k (up 9.6% from 1Q 2024). Net loss: US$2.69m (loss widened by 11% from 1Q 2024). US$0.70 loss ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-inbs/intelligent-bio-solutions/news/intelligent-bio-solutions-first-quarter-2025-earnings-us070\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INBS","symbol_name":"INTELLIGENT BIO SOLUTIONS INC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-inbs/intelligent-bio-solutions/news/intelligent-bio-solutions-first-quarter-2025-earnings-us070","article_id":"2483286696","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483286696","pubTimestamp":1731523148,"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Intelligent Bio Solutions ( NASDAQ:INBS ) First Quarter 2025 Results Key Financial Results Revenue: US$872.3k (up 9.6...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"INBS":"INTELLIGENT BIO SOLUTIONS INC"},"translate_title":"Intelligent Bio Solutions 2025年第一季度收益：每股亏损0.70美元（2024年第一季度亏损12.49美元）","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INBS":0.9},"content_text":"Intelligent Bio Solutions (NASDAQ:INBS) First Quarter 2025 ResultsKey Financial Results Revenue: US$872.3k (up 9.6% from 1Q 2024). Net loss: US$2.69m (loss widened by 11% from 1Q 2024). US$0.70 loss per share.  NasdaqCM:INBS Earnings and Revenue History November 13th 2024 All figures shown in the chart above are for the trailing 12 month (TTM) period Intelligent Bio Solutions shares are up 25% from a week ago.   Risk Analysis It's necessary to consider the ever-present spectre of investment risk.   We've identified 6 warning signs  with Intelligent Bio Solutions (at least 5 which can't be ignored), and understanding them should be part of your investment process. New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483286696"}